Tech Company Financing Transactions
Celeris Therapeutics Funding Round
European Innovation Council Fund participated in a $12.5 million funding round for Celeris Therapeutics. The round was recorded on 10/19/2022.
Transaction Overview
Company Name
Announced On
10/19/2022
Transaction Type
Venture Equity
Amount
$12,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
585 Glenwood Ave.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We design novel proximity-inducing compounds (PICs�), to treat diseases with high unmet medical need. Our patent-filed approach uses active machine learning to predict biomolecular interactions and generate new chemical entities. The wholly-owned pipeline is focused on degrader development in oncology and CNS disorders, while we are open to partnerships across all indication areas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Trummer
Chief Financial Officer
Jakob Hohenberger
Chief Scientific Officer
Markus Müllner
Chief Technical Officer
Noah Weber
Browse more venture capital transactions:
Prev: 10/19/2022: Landis venture capital transaction
Next: 10/19/2022: Noala venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs